Literature DB >> 12879270

Bullous lupus erythematosus in a patient with pre-existing dermatomyositis.

Joerg Wenzel1, Dirk Bokemeyer, Dagmar Wilsmann, Rainer Gerdsen, Thomas Tueting, Manfred Uerlich, Thomas Bieber.   

Abstract

The group of autoimmune cutaneous connective tissue diseases (CCTD) includes systemic sclerosis, dermatomyositis (DM), lupus erythematosus (LE), and subtypes. Most CCTD patients can be assigned to one of these phenotypes or mixed forms, and transitions among the subsets exist. We present the case of a 26-year-old woman with bullous LE and a background of pre-existing DM. Observations of transitions between DM and LE are extremely rare. Nevertheless, this case demonstrates the close relationship between these two disorders in the context of autoimmune connective tissue disease.

Entities:  

Mesh:

Year:  2003        PMID: 12879270     DOI: 10.1007/s00296-003-0354-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  6 in total

Review 1.  Bullous skin disease in lupus erythematosus.

Authors:  J A Yell; F Wojnarowska
Journal:  Lupus       Date:  1997       Impact factor: 2.911

2.  Bullous systemic lupus erythematosus: detection of antibodies against noncollagenous domain of type VII collagen.

Authors:  S Shirahama; F Furukawa; H Yagi; T Tanaka; T Hashimoto; M Takigawa
Journal:  J Am Acad Dermatol       Date:  1998-05       Impact factor: 11.527

Review 3.  Update on immunofluorescent testing in bullous diseases and lupus erythematosus.

Authors:  L E Gately; L T Nesbitt
Journal:  Dermatol Clin       Date:  1994-01       Impact factor: 3.478

4.  Bullous systemic lupus erythematosus: revised criteria for diagnosis.

Authors:  J A Yell; J Allen; F Wojnarowska; G Kirtschig; S M Burge
Journal:  Br J Dermatol       Date:  1995-06       Impact factor: 9.302

Review 5.  Humoral immunity in polymyositis/dermatomyositis.

Authors:  I N Targoff
Journal:  J Invest Dermatol       Date:  1993-01       Impact factor: 8.551

Review 6.  Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder.

Authors:  W R Gammon; R A Briggaman
Journal:  J Invest Dermatol       Date:  1993-01       Impact factor: 8.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.